• Publications
  • Influence
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
The production of guidelines for the management of drug-resistant tuberculosis (TB) fits the mandate of the World Health Organization (WHO) to support countries in the reinforcement of patient care.Expand
  • 979
  • 22
  • PDF
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis.
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are generally thought to have high mortality rates. However, many cases can be treated with the right combination andExpand
  • 482
  • 22
Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.
  • J. Caminero
  • Medicine
  • The international journal of tuberculosis and…
  • 1 April 2010
Although the multidrug-resistant tuberculosis (MDR-TB) epidemic is a very recent problem, many studies have attempted to understand it. We now have good estimates of the current burden (approximatelyExpand
  • 202
  • 10
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
Linezolid is used off-label to treat multidrug-resistant tuberculosis (MDR-TB) in absence of systematic evidence. We performed a systematic review and meta-analysis on efficacy, safety andExpand
  • 307
  • 9
Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island.
Molecular epidemiological studies suggest that particular Mycobacterium tuberculosis strains have an enhanced capacity to spread within a community. One strain, the Beijing genotype, has beenExpand
  • 187
  • 8
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) substantially challenges TB control, especially in the European Region of the World HealthExpand
  • 232
  • 6
  • PDF
Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease.
The frequency and determinants of exogenous reinfection and of endogenous reactivation of tuberculosis in patients previously treated are poorly understood. In Gran Canaria Island, Spain, betweenExpand
  • 168
  • 5
  • PDF
Current status of treatment completion and fatality among tuberculosis patients in Spain.
OBJECTIVES To determine treatment completion among patients with tuberculosis (TB), and to analyse factors associated with treatment default and fatality. METHODS A prospective cohort study ofExpand
  • 88
  • 5
Multidrug-resistant Tuberculosis Management in Resource-limited Settings
Managing MDRTB through national programs can yield results similar to those seen in wealthier settings.
  • 173
  • 4
  • PDF
European Union Standards for Tuberculosis Care
The European Centre for Disease Prevention and Control (ECDC) and the European Respiratory Society (ERS) jointly developed European Union Standards for Tuberculosis Care (ESTC) aimed at providingExpand
  • 207
  • 4
  • PDF